EA201490562A1 - Способы лечения связанной с инсультом сенсорно-двигательной недостаточности с использованием аминопиридинов - Google Patents

Способы лечения связанной с инсультом сенсорно-двигательной недостаточности с использованием аминопиридинов

Info

Publication number
EA201490562A1
EA201490562A1 EA201490562A EA201490562A EA201490562A1 EA 201490562 A1 EA201490562 A1 EA 201490562A1 EA 201490562 A EA201490562 A EA 201490562A EA 201490562 A EA201490562 A EA 201490562A EA 201490562 A1 EA201490562 A1 EA 201490562A1
Authority
EA
Eurasian Patent Office
Prior art keywords
aminopyridines
methods
treatment
insufficiency
associated touch
Prior art date
Application number
EA201490562A
Other languages
English (en)
Other versions
EA029558B1 (ru
Inventor
Эндрю Р. Блайт
Энтони О. Каджано
Том Дж. Пэрри
Дженнифер Ф. Айаси
Original Assignee
Акорда Терапьютикс. Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акорда Терапьютикс. Инк. filed Critical Акорда Терапьютикс. Инк.
Publication of EA201490562A1 publication Critical patent/EA201490562A1/ru
Publication of EA029558B1 publication Critical patent/EA029558B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

В заявке описаны способы и композиции, связанные с терапевтическим использованием аминопиридинов у пациентов со связанной с инсультом недостаточностью, в частности у пациентов со связанной с инсультом сенсорно-двигательной недостаточностью.
EA201490562A 2011-10-04 2012-10-04 Способы лечения связанной с инсультом сенсорно-двигательной недостаточности с использованием аминопиридинов EA029558B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161543150P 2011-10-04 2011-10-04
US201261591833P 2012-01-27 2012-01-27
US201261648695P 2012-05-18 2012-05-18
PCT/US2012/058607 WO2013052575A1 (en) 2011-10-04 2012-10-04 Methods for treating a stroke-related sensorimotor impairment using aminopyridines

Publications (2)

Publication Number Publication Date
EA201490562A1 true EA201490562A1 (ru) 2014-08-29
EA029558B1 EA029558B1 (ru) 2018-04-30

Family

ID=47143280

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490562A EA029558B1 (ru) 2011-10-04 2012-10-04 Способы лечения связанной с инсультом сенсорно-двигательной недостаточности с использованием аминопиридинов

Country Status (21)

Country Link
US (2) US20130085167A1 (ru)
EP (1) EP2766017B1 (ru)
JP (1) JP6134722B2 (ru)
KR (1) KR20140084120A (ru)
CN (2) CN104220072B (ru)
AR (1) AR088764A1 (ru)
AU (2) AU2012318719B2 (ru)
BR (1) BR112014008082A8 (ru)
CA (1) CA2850635A1 (ru)
CL (1) CL2014000799A1 (ru)
CO (1) CO7061067A2 (ru)
CR (1) CR20140153A (ru)
EA (1) EA029558B1 (ru)
HK (2) HK1201204A1 (ru)
IL (1) IL231809B (ru)
MX (1) MX354667B (ru)
SG (2) SG11201401248YA (ru)
TW (1) TWI592156B (ru)
UA (1) UA114486C2 (ru)
WO (1) WO2013052575A1 (ru)
ZA (1) ZA201402432B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014172266A1 (en) * 2013-04-15 2014-10-23 Acorda Therapeutics, Inc. Methods for treating sensorimotor impairments associated with certain types of stroke using aminopyridines
CN106511293B (zh) * 2015-09-11 2020-08-04 法德生技药品股份有限公司 含有达方吡啶的缓释口服制剂及其用途
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
CN109172573B (zh) * 2018-09-12 2021-01-26 黑龙江中桂制药有限公司 一种口服抗血栓药物及其用途
CN115018836A (zh) * 2022-08-08 2022-09-06 四川大学 一种癫痫病灶自动分割与预测方法、系统及设备

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 ４−アミノピリジン誘導体及びその酸付加塩
JPH03505868A (ja) * 1988-04-08 1991-12-19 マサチユセツツ・インスチチユート・オブ・テクノロジー 神経性疾患を治療するための方法及び組成物
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
CA2085785C (en) * 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition
US5952357A (en) 1993-12-23 1999-09-14 Cornell Research Foundation, Inc. Treating diseases of the anterior horn cells
AU3360000A (en) * 1999-02-09 2000-08-29 Uab Research Foundation Use of 4-amino pyridine for treatment of peripheral neuropathies
FR2791571B1 (fr) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
AU2001242184A1 (en) * 2000-03-28 2001-10-08 Queen:S University At Kingston Methods for effecting neuroprotection using a potassium channel modulator
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
US20100095132A1 (en) * 2007-01-26 2010-04-15 Safenet, Inc. Protecting secrets in an untrusted recipient
BR112013019265A2 (pt) * 2011-01-28 2016-10-11 Acorda Therapeutics Inc uso de bloqueadores do canal de potássio no tratamento da paralisia cerebral

Also Published As

Publication number Publication date
CN108451953A (zh) 2018-08-28
WO2013052575A1 (en) 2013-04-11
TWI592156B (zh) 2017-07-21
AR088764A1 (es) 2014-07-02
ZA201402432B (en) 2020-08-26
KR20140084120A (ko) 2014-07-04
NZ623255A (en) 2016-08-26
CN104220072A (zh) 2014-12-17
AU2012318719A1 (en) 2014-04-17
BR112014008082A8 (pt) 2018-01-16
MX2014003997A (es) 2014-07-22
US20160067232A1 (en) 2016-03-10
JP6134722B2 (ja) 2017-05-24
US20130085167A1 (en) 2013-04-04
TW201321000A (zh) 2013-06-01
CR20140153A (es) 2014-07-04
UA114486C2 (uk) 2017-06-26
CA2850635A1 (en) 2013-04-11
SG11201401248YA (en) 2014-05-29
EP2766017A1 (en) 2014-08-20
MX354667B (es) 2018-03-15
AU2012318719B2 (en) 2017-10-19
IL231809A0 (en) 2014-05-28
HK1204965A1 (en) 2015-12-11
CN104220072B (zh) 2018-04-17
CO7061067A2 (es) 2014-09-19
BR112014008082A2 (pt) 2017-07-18
CL2014000799A1 (es) 2014-11-03
EP2766017B1 (en) 2020-07-01
IL231809B (en) 2019-06-30
SG10201600410SA (en) 2016-02-26
EA029558B1 (ru) 2018-04-30
JP2014531470A (ja) 2014-11-27
AU2018200114A1 (en) 2018-01-25
HK1201204A1 (en) 2015-08-28

Similar Documents

Publication Publication Date Title
CY1120646T1 (el) Προγονικα κυτταρα μεσοδερμικης προελευσης
LTC3057969I2 (lt) Kompozicijos, naudojamos gydyti sutrikimams, susijusiems su kit
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
CO7020878A2 (es) Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
EA201590993A1 (ru) Гетеродимерные иммуноглобулины
BR112015020389A2 (pt) compostos carbazol úteis como inibidores de bromodomínio
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
EA201590931A1 (ru) Гетероциклические замещенные производные 2-амино-хиназолина для лечения вирусных инфекций
EA201500314A1 (ru) Лекарственные формы энзалутамида
EA201290590A1 (ru) Модифицированные туберкулезные антигены
UY34278A (es) Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades
IN2014DN07763A (ru)
AR089993A1 (es) Macrociclos peptidomimeticos
CO6950473A2 (es) Novedosos derivados de purina y su uso en el tratamiento de enfermedades
EA201270722A1 (ru) Формы рифаксимина и их применение
EA201590667A1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
TWD158887S (zh) 粉餅盒
IN2014DN06104A (ru)
PH12015502118A1 (en) Pyridin-4-yl derivatives
TWD161614S (zh) 瓶子之部分
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
EA201490562A1 (ru) Способы лечения связанной с инсультом сенсорно-двигательной недостаточности с использованием аминопиридинов
CO7151515A2 (es) Métodos para tratar deficiencia en la marcha y/o equilibrio en pacientes con esclerosis múltiple que utilizan una aminopiridina
EA201370204A1 (ru) Варианты нейротрофического фактора глиальных клеток (gdnf) человека

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM